Stay updated with breaking news from Registration Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SALT LAKE CITY, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Intermountain Precision Genomics, part of the Intermountain
--Registration Trial for uUTI Ongoing and On Track-- --Cash Runway until Mid-2024-- DUBLIN, Ireland and CHICAGO, May 12, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), a clinical-stage
Worldwide infection is like 0.2%, an order of magnitude lower into the us a bit higher. but nowhere near 2%. it is an enormous mistake and really unfortunate that we have a person who didn't have the expertise to lead the response. laura: doctor fauci's credibility, he is pushing pushing pushing this idea of vaccines on younger kids and hoping they will be ready by the end of this year. >> if you are a parent of a 12-year-old or 12 or younger how hopeful should you be that they will get a vaccine dose before thanksgiving? >> i'm cautiously optimistic about that. we hope that by the end of this...
ERC-USA ERC-USA Announces FDA Recommendation for Early Termination of Phase 2 Clinical Trial of ERC1671 (Gliovac or Sitoiganap) and Application for Registration Trial for Treatment of Glioblastoma ERC-USA Announces FDA Recommendation for Early Termination of Phase 2 Clinical Trial of ERC1671 (Gliovac or Sitoiganap) and Application for Registration Trial for Treatment of Glioblastoma IRVINE, Calif., April 07, 2021 (GLOBE NEWSWIRE) -- ERC-USA and the University of California, Irvine (UCI), today announce that the FDA has recommended early termination of the onging Phase 2 clinical trial title...